2023-09-13 |
2023-09-11 |
B
Purchase
|
Celebi John
President and CEO
Executive Director
|
500
+0.5%
0.85
USD 425
|
500
+0.5%
|
0.85
|
USD 425
|
|
2023-06-02 |
2023-06-01 |
S
Sale
|
Apeiron Investment Group Ltd.
Large shareholder
|
955,738
-100.0%
1.58
USD 1,510,066
|
955,738
-100.0%
|
1.58
|
USD 1,510,066
|
|
2023-06-02 |
2023-06-01 |
S
Sale
|
Apeiron Investment Group Ltd.
Large shareholder
|
2,485,923
-100.0%
1.58
USD 3,927,758
|
2,485,923
-100.0%
|
1.58
|
USD 3,927,758
|
|
2023-02-27 |
2023-02-23 |
B
Purchase
|
Apeiron Investment Group Ltd.
Large shareholder
|
1,100
+0.0%
1.60
USD 1,763
|
1,100
+0.0%
|
1.60
|
USD 1,763
|
|
2023-02-27 |
2023-02-23 |
B
Purchase
|
Apeiron Investment Group Ltd.
Large shareholder
|
1,100
+0.0%
1.62
USD 1,777
|
1,100
+0.0%
|
1.62
|
USD 1,777
|
|
2022-03-02 |
2022-03-02 |
B
Purchase
|
Peyer James
Non-Executive Director
Large shareholder
|
1,203
+0.0%
3.20
USD 3,850
|
1,203
+0.0%
|
3.20
|
USD 3,850
|
|
2022-03-02 |
2022-03-02 |
B
Purchase
|
Cambrian BioPharma Inc
Large shareholder
|
1,203
+0.0%
3.20
USD 3,850
|
1,203
+0.0%
|
3.20
|
USD 3,850
|
|
2022-03-01 |
2022-03-01 |
B
Purchase
|
Cambrian BioPharma Inc
Large shareholder
|
2,458
+0.0%
3.60
USD 8,849
|
2,458
+0.0%
|
3.60
|
USD 8,849
|
|
2022-03-01 |
2022-03-01 |
B
Purchase
|
Peyer James
Non-Executive Director
Large shareholder
|
2,458
+0.0%
3.60
USD 8,849
|
2,458
+0.0%
|
3.60
|
USD 8,849
|
|
2022-03-01 |
2022-02-28 |
B
Purchase
|
Cambrian BioPharma Inc
Large shareholder
|
42
+0.0%
3.60
USD 151
|
42
+0.0%
|
3.60
|
USD 151
|
|
2022-03-01 |
2022-02-28 |
B
Purchase
|
Peyer James
Non-Executive Director
Large shareholder
|
42
+0.0%
3.60
USD 151
|
42
+0.0%
|
3.60
|
USD 151
|
|
2022-02-28 |
2022-02-25 |
B
Purchase
|
Cambrian BioPharma Inc
Large shareholder
|
2,500
+0.0%
3.65
USD 9,125
|
2,500
+0.0%
|
3.65
|
USD 9,125
|
|
2022-02-28 |
2022-02-25 |
B
Purchase
|
Peyer James
Non-Executive Director
Large shareholder
|
2,500
+0.0%
3.65
USD 9,125
|
2,500
+0.0%
|
3.65
|
USD 9,125
|
|
2022-02-24 |
2022-02-24 |
B
Purchase
|
Peyer James
Non-Executive Director
Large shareholder
|
15,000
+0.3%
3.63
USD 54,450
|
15,000
+0.3%
|
3.63
|
USD 54,450
|
|
2022-02-24 |
2022-02-24 |
B
Purchase
|
Cambrian BioPharma Inc
Large shareholder
|
15,000
+0.3%
3.63
USD 54,450
|
15,000
+0.3%
|
3.63
|
USD 54,450
|
|
2022-02-24 |
2022-02-23 |
B
Purchase
|
Peyer James
Non-Executive Director
Large shareholder
|
2,500
+0.0%
3.80
USD 9,500
|
2,500
+0.0%
|
3.80
|
USD 9,500
|
|
2022-02-24 |
2022-02-23 |
B
Purchase
|
Cambrian BioPharma Inc
Large shareholder
|
2,500
+0.0%
3.80
USD 9,500
|
2,500
+0.0%
|
3.80
|
USD 9,500
|
|
2022-02-22 |
2022-02-18 |
B
Purchase
|
Cambrian BioPharma Inc
Large shareholder
|
15,000
+0.3%
3.97
USD 59,550
|
15,000
+0.3%
|
3.97
|
USD 59,550
|
|
2022-02-22 |
2022-02-18 |
B
Purchase
|
Peyer James
Non-Executive Director
Large shareholder
|
15,000
+0.3%
3.97
USD 59,550
|
15,000
+0.3%
|
3.97
|
USD 59,550
|
|
2022-02-22 |
2022-02-17 |
B
Purchase
|
Cambrian BioPharma Inc
Large shareholder
|
4,949
+0.1%
4.17
USD 20,637
|
4,949
+0.1%
|
4.17
|
USD 20,637
|
|
2022-02-22 |
2022-02-17 |
B
Purchase
|
Peyer James
Non-Executive Director
Large shareholder
|
4,949
+0.1%
4.17
USD 20,637
|
4,949
+0.1%
|
4.17
|
USD 20,637
|
|
2022-02-16 |
2022-02-16 |
B
Purchase
|
Cambrian BioPharma Inc
Large shareholder
|
2,551
+0.0%
4.25
USD 10,842
|
2,551
+0.0%
|
4.25
|
USD 10,842
|
|
2022-02-16 |
2022-02-16 |
B
Purchase
|
Peyer James
Non-Executive Director
Large shareholder
|
2,551
+0.0%
4.25
USD 10,842
|
2,551
+0.0%
|
4.25
|
USD 10,842
|
|
2022-02-16 |
2022-02-14 |
B
Purchase
|
Cambrian BioPharma Inc
Large shareholder
|
10,000
+0.2%
4.18
USD 41,800
|
10,000
+0.2%
|
4.18
|
USD 41,800
|
|
2022-02-16 |
2022-02-14 |
B
Purchase
|
Peyer James
Non-Executive Director
Large shareholder
|
10,000
+0.2%
4.18
USD 41,800
|
10,000
+0.2%
|
4.18
|
USD 41,800
|
|
2022-02-14 |
2022-02-11 |
B
Purchase
|
Cambrian BioPharma Inc
Large shareholder
|
12,500
+0.2%
4.40
USD 55,000
|
12,500
+0.2%
|
4.40
|
USD 55,000
|
|
2022-02-14 |
2022-02-11 |
B
Purchase
|
Peyer James
Non-Executive Director
Large shareholder
|
12,500
+0.2%
4.40
USD 55,000
|
12,500
+0.2%
|
4.40
|
USD 55,000
|
|
2022-02-14 |
2022-02-10 |
B
Purchase
|
Cambrian BioPharma Inc
Large shareholder
|
5,000
+0.1%
4.58
USD 22,900
|
5,000
+0.1%
|
4.58
|
USD 22,900
|
|
2022-02-14 |
2022-02-10 |
B
Purchase
|
Peyer James
Non-Executive Director
Large shareholder
|
5,000
+0.1%
4.58
USD 22,900
|
5,000
+0.1%
|
4.58
|
USD 22,900
|
|
2022-02-08 |
2022-02-08 |
B
Purchase
|
Cambrian BioPharma Inc
Large shareholder
|
10,000
+0.2%
4.33
USD 43,300
|
10,000
+0.2%
|
4.33
|
USD 43,300
|
|
2022-02-08 |
2022-02-08 |
B
Purchase
|
Peyer James
Non-Executive Director
Large shareholder
|
10,000
+0.2%
4.33
USD 43,300
|
10,000
+0.2%
|
4.33
|
USD 43,300
|
|
2022-02-08 |
2022-02-04 |
B
Purchase
|
Cambrian BioPharma Inc
Large shareholder
|
2,500
+0.0%
4.45
USD 11,125
|
2,500
+0.0%
|
4.45
|
USD 11,125
|
|
2022-02-08 |
2022-02-04 |
B
Purchase
|
Peyer James
Non-Executive Director
Large shareholder
|
2,500
+0.0%
4.45
USD 11,125
|
2,500
+0.0%
|
4.45
|
USD 11,125
|
|
2022-02-08 |
2022-02-03 |
B
Purchase
|
Cambrian BioPharma Inc
Large shareholder
|
17,500
+0.3%
4.65
USD 81,375
|
17,500
+0.3%
|
4.65
|
USD 81,375
|
|
2022-02-08 |
2022-02-03 |
B
Purchase
|
Peyer James
Non-Executive Director
Large shareholder
|
17,500
+0.3%
4.65
USD 81,375
|
17,500
+0.3%
|
4.65
|
USD 81,375
|
|
2022-01-31 |
2022-01-28 |
B
Purchase
|
Peyer James
Non-Executive Director
Large shareholder
|
8,900
+0.2%
4.22
USD 37,558
|
8,900
+0.2%
|
4.22
|
USD 37,558
|
|
2022-01-31 |
2022-01-28 |
B
Purchase
|
Cambrian BioPharma Inc
Large shareholder
|
8,900
+0.2%
4.22
USD 37,558
|
8,900
+0.2%
|
4.22
|
USD 37,558
|
|
2022-01-31 |
2022-01-27 |
B
Purchase
|
Peyer James
Non-Executive Director
Large shareholder
|
6,100
+0.1%
4.31
USD 26,291
|
6,100
+0.1%
|
4.31
|
USD 26,291
|
|
2022-01-31 |
2022-01-27 |
B
Purchase
|
Cambrian BioPharma Inc
Large shareholder
|
6,100
+0.1%
4.31
USD 26,291
|
6,100
+0.1%
|
4.31
|
USD 26,291
|
|
2022-01-27 |
2022-01-26 |
B
Purchase
|
Cambrian BioPharma Inc
Large shareholder
|
29,900
+0.6%
4.62
USD 138,138
|
29,900
+0.6%
|
4.62
|
USD 138,138
|
|
2022-01-27 |
2022-01-26 |
B
Purchase
|
Peyer James
Non-Executive Director
Large shareholder
|
29,900
+0.6%
4.62
USD 138,138
|
29,900
+0.6%
|
4.62
|
USD 138,138
|
|
2022-01-27 |
2022-01-25 |
B
Purchase
|
Cambrian BioPharma Inc
Large shareholder
|
20,100
+0.4%
4.86
USD 97,686
|
20,100
+0.4%
|
4.86
|
USD 97,686
|
|
2022-01-27 |
2022-01-25 |
B
Purchase
|
Peyer James
Non-Executive Director
Large shareholder
|
20,100
+0.4%
4.86
USD 97,686
|
20,100
+0.4%
|
4.86
|
USD 97,686
|
|
2022-01-25 |
2022-01-24 |
B
Purchase
|
Cambrian BioPharma Inc
Large shareholder
|
22,707
+0.5%
4.69
USD 106,496
|
22,707
+0.5%
|
4.69
|
USD 106,496
|
|
2022-01-25 |
2022-01-24 |
B
Purchase
|
Peyer James
Non-Executive Director
Large shareholder
|
22,707
+0.5%
4.69
USD 106,496
|
22,707
+0.5%
|
4.69
|
USD 106,496
|
|
2022-01-25 |
2022-01-21 |
B
Purchase
|
Cambrian BioPharma Inc
Large shareholder
|
24,703
+0.5%
4.94
USD 122,033
|
24,703
+0.5%
|
4.94
|
USD 122,033
|
|
2022-01-25 |
2022-01-21 |
B
Purchase
|
Peyer James
Non-Executive Director
Large shareholder
|
24,703
+0.5%
4.94
USD 122,033
|
24,703
+0.5%
|
4.94
|
USD 122,033
|
|
2022-01-21 |
2022-01-20 |
B
Purchase
|
Peyer James
Non-Executive Director
Large shareholder
|
20,000
+0.4%
5.17
USD 103,400
|
20,000
+0.4%
|
5.17
|
USD 103,400
|
|
2022-01-21 |
2022-01-20 |
B
Purchase
|
Cambrian BioPharma Inc
Large shareholder
|
20,000
+0.4%
5.17
USD 103,400
|
20,000
+0.4%
|
5.17
|
USD 103,400
|
|
2022-01-21 |
2022-01-19 |
B
Purchase
|
Peyer James
Non-Executive Director
Large shareholder
|
10,244
+0.2%
4.97
USD 50,913
|
10,244
+0.2%
|
4.97
|
USD 50,913
|
|
2022-01-21 |
2022-01-19 |
B
Purchase
|
Cambrian BioPharma Inc
Large shareholder
|
10,244
+0.2%
4.97
USD 50,913
|
10,244
+0.2%
|
4.97
|
USD 50,913
|
|
2022-01-20 |
2022-01-18 |
B
Purchase
|
Cambrian BioPharma Inc
Large shareholder
|
10,000
+0.2%
5.08
USD 50,800
|
10,000
+0.2%
|
5.08
|
USD 50,800
|
|
2022-01-20 |
2022-01-18 |
B
Purchase
|
Peyer James
Non-Executive Director
Large shareholder
|
10,000
+0.2%
5.08
USD 50,800
|
10,000
+0.2%
|
5.08
|
USD 50,800
|
|
2022-01-18 |
2022-01-14 |
B
Purchase
|
Cambrian BioPharma Inc
Large shareholder
|
6,219
+0.1%
4.99
USD 31,033
|
6,219
+0.1%
|
4.99
|
USD 31,033
|
|
2022-01-18 |
2022-01-14 |
B
Purchase
|
Peyer James
Non-Executive Director
Large shareholder
|
6,219
+0.1%
4.99
USD 31,033
|
6,219
+0.1%
|
4.99
|
USD 31,033
|
|
2022-01-18 |
2022-01-13 |
B
Purchase
|
Cambrian BioPharma Inc
Large shareholder
|
19,953
+0.4%
5.13
USD 102,359
|
19,953
+0.4%
|
5.13
|
USD 102,359
|
|
2022-01-18 |
2022-01-13 |
B
Purchase
|
Peyer James
Non-Executive Director
Large shareholder
|
19,953
+0.4%
5.13
USD 102,359
|
19,953
+0.4%
|
5.13
|
USD 102,359
|
|
2022-01-13 |
2022-01-12 |
B
Purchase
|
Peyer James
Non-Executive Director
Large shareholder
|
9,202
+0.2%
5.22
USD 48,034
|
9,202
+0.2%
|
5.22
|
USD 48,034
|
|
2022-01-13 |
2022-01-12 |
B
Purchase
|
Cambrian BioPharma Inc
Large shareholder
|
9,202
+0.2%
5.22
USD 48,034
|
9,202
+0.2%
|
5.22
|
USD 48,034
|
|
2022-01-13 |
2022-01-11 |
B
Purchase
|
Peyer James
Non-Executive Director
Large shareholder
|
10,845
+0.2%
5.18
USD 56,177
|
10,845
+0.2%
|
5.18
|
USD 56,177
|
|
2022-01-13 |
2022-01-11 |
B
Purchase
|
Cambrian BioPharma Inc
Large shareholder
|
10,845
+0.2%
5.18
USD 56,177
|
10,845
+0.2%
|
5.18
|
USD 56,177
|
|
2022-01-11 |
2022-01-10 |
B
Purchase
|
Cambrian BioPharma Inc
Large shareholder
|
10,000
+0.2%
5.28
USD 52,800
|
10,000
+0.2%
|
5.28
|
USD 52,800
|
|
2022-01-11 |
2022-01-10 |
B
Purchase
|
Peyer James
Non-Executive Director
Large shareholder
|
10,000
+0.2%
5.28
USD 52,800
|
10,000
+0.2%
|
5.28
|
USD 52,800
|
|
2022-01-03 |
2021-12-30 |
B
Purchase
|
Cambrian BioPharma Inc
Large shareholder
|
1,127
+0.0%
4.85
USD 5,466
|
1,127
+0.0%
|
4.85
|
USD 5,466
|
|
2022-01-03 |
2021-12-30 |
B
Purchase
|
Peyer James
Non-Executive Director
Large shareholder
|
1,127
+0.0%
4.85
USD 5,466
|
1,127
+0.0%
|
4.85
|
USD 5,466
|
|
2021-12-23 |
2021-12-23 |
B
Purchase
|
Cambrian BioPharma Inc
Large shareholder
|
11,000
+0.2%
5.27
USD 57,970
|
11,000
+0.2%
|
5.27
|
USD 57,970
|
|
2021-12-23 |
2021-12-23 |
B
Purchase
|
Peyer James
Non-Executive Director
Large shareholder
|
11,000
+0.2%
5.27
USD 57,970
|
11,000
+0.2%
|
5.27
|
USD 57,970
|
|
2021-12-21 |
2021-12-17 |
B
Purchase
|
Cambrian BioPharma Inc
Large shareholder
|
117
+0.0%
5.29
USD 619
|
117
+0.0%
|
5.29
|
USD 619
|
|
2021-12-21 |
2021-12-17 |
B
Purchase
|
Peyer James
Non-Executive Director
Large shareholder
|
117
+0.0%
5.29
USD 619
|
117
+0.0%
|
5.29
|
USD 619
|
|
2021-12-20 |
2021-12-16 |
B
Purchase
|
Peyer James
Non-Executive Director
Large shareholder
|
10,925
+0.2%
5.25
USD 57,356
|
10,925
+0.2%
|
5.25
|
USD 57,356
|
|
2021-12-20 |
2021-12-16 |
B
Purchase
|
Cambrian BioPharma Inc
Large shareholder
|
10,925
+0.2%
5.25
USD 57,356
|
10,925
+0.2%
|
5.25
|
USD 57,356
|
|
2021-12-13 |
2021-12-10 |
B
Purchase
|
RICKS THOMAS G
Non-Executive Director
|
20,000
+6.2%
5.86
USD 117,200
|
20,000
+6.2%
|
5.86
|
USD 117,200
|
|
2021-12-13 |
2021-12-09 |
B
Purchase
|
RICKS THOMAS G
Non-Executive Director
|
20,000
+6.6%
6.62
USD 132,400
|
20,000
+6.6%
|
6.62
|
USD 132,400
|
|
2021-05-06 |
2021-05-05 |
B
Purchase
|
Cambrian BioPharma Inc
Large shareholder
|
350
+0.0%
12.00
USD 4,200
|
350
+0.0%
|
12.00
|
USD 4,200
|
|
2021-04-21 |
2021-04-20 |
B
Purchase
|
Cambrian BioPharma Inc
Large shareholder
|
385
+0.0%
12.77
USD 4,916
|
385
+0.0%
|
12.77
|
USD 4,916
|
|